293 related articles for article (PubMed ID: 30022424)
1. Efficacy of High-Dose Liraglutide as an Adjunct for Weight Loss in Patients with Prior Bariatric Surgery.
Rye P; Modi R; Cawsey S; Sharma AM
Obes Surg; 2018 Nov; 28(11):3553-3558. PubMed ID: 30022424
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of liraglutide 3.0 mg treatment on weight loss in patients with weight regain after bariatric surgery.
Muratori F; Vignati F; Di Sacco G; Gavazzi L; Pellegrino D; Del Prete M
Eat Weight Disord; 2022 Oct; 27(7):2775-2781. PubMed ID: 35763245
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of Laparoscopic Sleeve Gastrectomy and Roux-en-Y Gastric Bypass in Patients Older than 60.
Abbas M; Cumella L; Zhang Y; Choi J; Vemulapalli P; Melvin WS; Camacho D
Obes Surg; 2015 Dec; 25(12):2251-6. PubMed ID: 26001882
[TBL] [Abstract][Full Text] [Related]
4. The utility of weight loss medications after bariatric surgery for weight regain or inadequate weight loss: A multi-center study.
Stanford FC; Alfaris N; Gomez G; Ricks ET; Shukla AP; Corey KE; Pratt JS; Pomp A; Rubino F; Aronne LJ
Surg Obes Relat Dis; 2017 Mar; 13(3):491-500. PubMed ID: 27986587
[TBL] [Abstract][Full Text] [Related]
5. Liraglutide Effects on Upper Gastrointestinal Investigations: Implications Prior to Bariatric Surgery.
Modi R; Rye P; Cawsey S; Birch DW; Sharma AM
Obes Surg; 2018 Jul; 28(7):2113-2116. PubMed ID: 29667023
[TBL] [Abstract][Full Text] [Related]
6. Association of Bariatric Surgery Using Laparoscopic Banding, Roux-en-Y Gastric Bypass, or Laparoscopic Sleeve Gastrectomy vs Usual Care Obesity Management With All-Cause Mortality.
Reges O; Greenland P; Dicker D; Leibowitz M; Hoshen M; Gofer I; Rasmussen-Torvik LJ; Balicer RD
JAMA; 2018 Jan; 319(3):279-290. PubMed ID: 29340677
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and Safety of Liraglutide in Managing Inadequate Weight Loss and Weight Regain after Primary and Revisional Bariatric Surgery: Anthropometric and Cardiometabolic Outcomes.
Elhag W; El Ansari W
Obes Surg; 2022 Apr; 32(4):1005-1015. PubMed ID: 35060021
[TBL] [Abstract][Full Text] [Related]
8. Liraglutide 3.0 mg for the management of insufficient weight loss or excessive weight regain post-bariatric surgery.
Wharton S; Kuk JL; Luszczynski M; Kamran E; Christensen RAG
Clin Obes; 2019 Aug; 9(4):e12323. PubMed ID: 31183988
[TBL] [Abstract][Full Text] [Related]
9. Utilization of Anti-obesity Medications After Bariatric Surgery: Analysis of a Large National Database.
Firkins SA; Chittajallu V; Flora B; Yoo H; Simons-Linares R
Obes Surg; 2024 May; 34(5):1415-1424. PubMed ID: 38512645
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of semaglutide versus liraglutide for treating post-metabolic and bariatric surgery weight recurrence.
Murvelashvili N; Xie L; Schellinger JN; Mathew MS; Marroquin EM; Lingvay I; Messiah SE; Almandoz JP
Obesity (Silver Spring); 2023 May; 31(5):1280-1289. PubMed ID: 36998152
[TBL] [Abstract][Full Text] [Related]
11. Liraglutide 3.0 mg (Saxenda©) for Weight Loss and Remission of Pre-Diabetes. Real-World Clinical Evaluation of Effectiveness among Patients Awaiting Bariatric Surgery.
Wilmington R; Ardavani A; Simenacz A; Green C; Idris I
Obes Surg; 2024 Jan; 34(1):286-289. PubMed ID: 38012508
[TBL] [Abstract][Full Text] [Related]
12. Revisional Gastric Bypass for Failed Restrictive Procedures: Comparison of Single-Anastomosis (Mini-) and Roux-en-Y Gastric Bypass.
Almalki OM; Lee WJ; Chen JC; Ser KH; Lee YC; Chen SC
Obes Surg; 2018 Apr; 28(4):970-975. PubMed ID: 29101719
[TBL] [Abstract][Full Text] [Related]
13. Gastric band conversion to Roux-en-Y gastric bypass shows greater weight loss than conversion to sleeve gastrectomy: 5-year outcomes.
Creange C; Jenkins M; Pergamo M; Fielding G; Ren-Fielding C; Schwack B
Surg Obes Relat Dis; 2018 Oct; 14(10):1531-1536. PubMed ID: 30449510
[TBL] [Abstract][Full Text] [Related]
14. Comparative effectiveness of 3 bariatric surgery procedures: Roux-en-Y gastric bypass, laparoscopic adjustable gastric band, and sleeve gastrectomy.
Lee JH; Nguyen QN; Le QA
Surg Obes Relat Dis; 2016 Jun; 12(5):997-1002. PubMed ID: 27220823
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with long-term weight-loss maintenance following bariatric surgery in adolescents with severe obesity.
Ryder JR; Gross AC; Fox CK; Kaizer AM; Rudser KD; Jenkins TM; Ratcliff MB; Kelly AS; Kirk S; Siegel RM; Inge TH
Int J Obes (Lond); 2018 Jan; 42(1):102-107. PubMed ID: 28894289
[TBL] [Abstract][Full Text] [Related]
16. Intragastric balloon outcomes in super-obesity: a 16-year city center hospital series.
Ashrafian H; Monnich M; Braby TS; Smellie J; Bonanomi G; Efthimiou E
Surg Obes Relat Dis; 2018 Nov; 14(11):1691-1699. PubMed ID: 30193905
[TBL] [Abstract][Full Text] [Related]
17. Cost-Effectiveness Analysis of Bariatric Surgery for Morbid Obesity.
Alsumali A; Eguale T; Bairdain S; Samnaliev M
Obes Surg; 2018 Aug; 28(8):2203-2214. PubMed ID: 29335933
[TBL] [Abstract][Full Text] [Related]
18. Influence of Patient Choice on Outcome of Bariatric Surgery.
Vasas P; Nehemiah S; Hussain A; Finney J; Kirk K; Yeluri S; Balchandra S
Obes Surg; 2018 Feb; 28(2):483-488. PubMed ID: 28795291
[TBL] [Abstract][Full Text] [Related]
19. Risk of de-novo inflammatory bowel disease among obese patients treated with bariatric surgery or weight loss medications.
Kochhar GS; Desai A; Syed A; Grover A; El Hachem S; Abdul-Baki H; Chintamaneni P; Aoun E; Kanna S; Sandhu DS; Singh S; Shen B; Loftus EV; Dulai PS
Aliment Pharmacol Ther; 2020 Jun; 51(11):1067-1075. PubMed ID: 32319111
[TBL] [Abstract][Full Text] [Related]
20. Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial.
Halawi H; Khemani D; Eckert D; O'Neill J; Kadouh H; Grothe K; Clark MM; Burton DD; Vella A; Acosta A; Zinsmeister AR; Camilleri M
Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):890-899. PubMed ID: 28958851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
